Unique ID issued by UMIN | UMIN000020086 |
---|---|
Receipt number | R000023197 |
Scientific Title | The multicenter clinical study of the relation between a SGLT2 inhibitor and the hormones regulating appetite in the patients with type 2 diabetes |
Date of disclosure of the study information | 2015/12/14 |
Last modified on | 2016/02/25 15:01:11 |
The multicenter clinical study of the relation between a SGLT2 inhibitor and the hormones regulating appetite in the patients with type 2 diabetes
Study for the relation between a SGLT2 inhibitor and the hormones regulating appetite
The multicenter clinical study of the relation between a SGLT2 inhibitor and the hormones regulating appetite in the patients with type 2 diabetes
Study for the relation between a SGLT2 inhibitor and the hormones regulating appetite
Japan |
Type 2 diabetes
Endocrinology and Metabolism |
Others
NO
To clarify the relation between a SGLT2 inhibitor (Canagliflozin) and the changes of hormones regulating appetite
Safety,Efficacy
The changes of the hormones regulating appetite (active ghrelin and PYY) after 12 weeks from start of administrating of Canagliflozin
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Oral administration of 100 mg Canagliflozin once a day after breakfast for 24 weeks
20 | years-old | <= |
65 | years-old | > |
Male and Female
1. Patients under diet therapy and exercise
2. Patients without medicine or with under 2 types of diabetic medicines for 2 months except for an another SGLT2 inhibitor
3. HbA1c (NGSP) over 7.0 % or under 10 %
4. Patients who can understand the study and agree with the study by the document
1. Patients with an allergy to Canagliflozin
2. Patients with diabetic ketoacidosis, diabetic coma and type 1 diabetes
3. Patients with over 2 times from upper limit of normal ranges of AST, ALT, or gamma-GTP
4. Patients with under 45 ml/min/1.73m2 of eGFR
5. Patients with severe inflammation or injury, or before or after operation
6. Patients with cancer or inflammatory bowel disease, or after operation of GI tracts
7. Patients with pregnancy or during lactation
8. Patients who are thought to be unsuitable for the study by the attending doctor
100
1st name | |
Middle name | |
Last name | Naotsuka Okayama |
Nagoya City University Graduate School of Medical Sciences
Department of Gastroenterology and Metabolism
1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Japan
052-853-8211
nokaya@med.nagoya-cu.ac.jp
1st name | |
Middle name | |
Last name | Naotsuka Okayama |
Nagoya City University Graduate School of Medical Sciences
Department of Gastroenterology and Metabolism
1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Japan
052-853-8211
nokaya@med.nagoya-cu.ac.jp
Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences
Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences
Self funding
Nagoya City East Medical Center
Nagoya City West Medical Center
Kariya Toyota General Hospital
Chita Kosei Hospital
Asahi Rousai Hospital
Toyokawa City Hospital
Nishitita General Hospital
Takahashi Family Clinic
Okouchi Internal Medicine Clinic
NO
名古屋市立大学病院(愛知県)、名古屋市立東部医療センター(愛知県)、名古屋市立西部医療センター(愛知県)、刈谷豊田総合病院(愛知県)、愛知県厚生連知多厚生病院(愛知県)、旭労災病院(愛知県)、豊川市民病院(愛知県)、公立西知多総合病院(愛知県)、高橋ファミリークリニック(愛知県)、おおこうち内科クリニック(愛知県)、
2015 | Year | 12 | Month | 14 | Day |
Unpublished
Enrolling by invitation
2015 | Year | 12 | Month | 02 | Day |
2015 | Year | 12 | Month | 14 | Day |
2015 | Year | 12 | Month | 06 | Day |
2016 | Year | 02 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023197